Home
Conditions
Anemia, Refractory, with Excess of Blasts

Clinical trial condition

Anemia, Refractory, with Excess of Blasts

Explore clinical trials studying Anemia, Refractory, with Excess of Blasts. Study availability and eligibility vary by location and protocol.

249 public trials 37 recruiting studies

Refine in advanced search Browse all conditions

Anemia, Refractory, with Excess of Blasts trial results

Recruiting

Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS

NCT06680752

Conditions: Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Anemia, +12 more
Locations: Novant Health Cancer Institute Charlotte, North Carolina, United States

Novant Health Cancer Institute Winston-Salem, North Carolina, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

NCT02143830

Conditions: Acute Myelogenous Leukemia (AML), Anemia, Anemia, Aplastic, +23 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Recruiting

Oral-ATO for TP53-mutated Myeloid Malignancies

NCT06778187

Conditions: Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +20 more
Locations: Queen Mary Hospital, Hong Kong Hong Kong

View Trial Details

Recruiting

Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation

NCT06892223

Conditions: Acute Myeloid Leukaemia, Anemia, Anemia, Refractory, +13 more
Locations: IRCCS Ospedale Policlinico San Martino Genova, GENOVA, Italy

Irccs Istituto Clinico Humanitas Rozzano, MILANO, Italy

View Trial Details

Recruiting

Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors

NCT06785077

Conditions: Adnexal Diseases, Anemia, Anemia, Refractory, +28 more
Locations: Istituto Europeo di Oncologia Milan, Italy

View Trial Details

Recruiting

Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS

NCT04741945

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +10 more
Locations: Rigshospitalet Copenhagen, Copenhagen N, Denmark

View Trial Details

Recruiting

Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement

NCT06111612

Conditions: Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +23 more
Locations: Shanghai General Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

Plasmatic Biomarkers Associated With Short-term Luspatercept Treatment of Lower Risk Myelodysplastic Syndromes (MDS) Patients

NCT07830004

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +5 more
Locations: Not specified

View Trial Details

Not yet recruiting

Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies

NCT07710781

Conditions: Acute Biphenotypic Leukemia, Acute Leukemia, Acute Lymphoblastic Leukemia, +42 more
Locations: Not specified

View Trial Details

Not yet recruiting

Dresden MDS Registry With an Accompanying Biomaterial Collection

NCT07561385

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +8 more
Locations: Universitätsklinikum Carl Gustav Carus Dresden Dresden, Germany

View Trial Details

Anemia, Refractory, with Excess of Blasts

Anemia, Refractory, with Excess of Blasts trial results

Related conditions